Drawing for MESOBLAST

USPTO serial 79018738

MESOBLAST

Reviewed by CopyMark Law Group

Reg. 3275342Status 706Renewal
Filing date
Status date
Registration date
Aug 7, 2007
Examiner
HOFFMAN, DAVID AARON
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with MESOBLAST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Monica Riva Talley

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1100 New York Avenue, N.W.Washington, DC 20005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; veterinary preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; biotechnology preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; medical preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; diagnostic preparations and reagents for medical purposes; culture fluids, namely, cultures of micro-organisms for medical purposes; human allograft tissue; animal allograft tissue; human tissue and animal tissue for transplantation or implantation, medical and surgical purposes; human cells including stem cells, animal cells including stem cells for medical or clinical use; pharmaceutical preparations for the treatment, reconstruction and repair of tissueACTIVE—
042Scientific, medical research, clinical research, pharmaceutical research and development, advisory and consultancy services in the field of T-cell production, T-cell immunotherapy, cell culture devices, tissue engineering for cellular applications for humans and animals, stem cell banking, tissue banking, drug discovery, vaccine screening, cell culture methods, cell expansion technology including stem cell expansion technology, cellular therapies including stem cell therapies and cellular transplantsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 7, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 26, 2026LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Apr 11, 2025LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Apr 3, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Aug 10, 2017NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Aug 10, 201771AGREGISTERED-SEC.71 ACCEPTED—
Aug 7, 2017ES71TEAS SECTION 71 RECEIVED—
Jul 7, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 25, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 25, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 7, 2016REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jul 17, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 16, 2015RNWLINTERNATIONAL REGISTRATION RENEWED—
Nov 29, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 21, 2013NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Mar 21, 201371AGREGISTERED-SEC.71 ACCEPTED—
Mar 21, 2013EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jan 15, 2013PR71POST REGISTRATION ACTION MAILED - SEC.71—
Jan 15, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 24, 2012ES71TEAS SECTION 71 RECEIVED—
Dec 24, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 23, 2011ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 26, 2009FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 5, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 5, 2007FIMPFINAL DISPOSITION PROCESSED—
Nov 19, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 7, 2007EXPTEXPARTE APPEAL TERMINATED—
Aug 7, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 1, 2007MAILPAPER RECEIVED—
Jun 14, 2007OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 31, 2007OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 31, 2007OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 22, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2007NPUBNOTICE OF PUBLICATION—
Mar 22, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 22, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 22, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 22, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2007ALIEASSIGNED TO LIE—
Feb 16, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 16, 2007EXPIEX PARTE APPEAL-INSTITUTED—
Feb 16, 2007JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Feb 16, 2007EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Aug 17, 2006CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 16, 2006CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 19, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 16, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 16, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 3, 2006RFNTREFUSAL PROCESSED BY IB—
Jan 17, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 12, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 11, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 3, 2006DOCKASSIGNED TO EXAMINER—
Jan 3, 2006NWAPNEW APPLICATION ENTERED—
Dec 30, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance